Current drugs for pancreatic cancer lose effectiveness within months because the tumour becomes resistant. The group from ...

To kick off mock draft season, I decided to use mock drafts as a way to start our look at potential draft targets for the Dolphins this year. I visited our friends at Pro Football and Sports Network ...

As darkness retreats and flotation tanks gain popularity, a UCSD professor examines how “sensory deprivation” experiments ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after prior targeted treatment.

Discusses 2026 Clinical Pipeline Outlook and Anticipated Trial Updates February 2, 2026 7:01 PM ESTCompany ParticipantsGary ...

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

Detailed price information for Corvus Pharma Com (CRVS-Q) from The Globe and Mail including charting and trades.

In case you've faced some hurdles solving the clue, Completely fill, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test ...

Looking ahead to upcoming milestones, we expect to report phase one data for o five eight in the second half of this year, ...

Proteins are the building blocks of life. These biomolecules comprise chains of amino acids that fold into precise shapes to perform specific jobs in nature. But these elegant structures form only ...

Albert Bourla: 2025 was a very good year for Pfizer Inc. I'm very pleased with strong execution to deliver and, frankly, overdeliver on our financial commitments. If successful, we will substantially ...